Financials in USD. Standardized financial statements.
A compact view of how Ekso Bionics Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $12.80M | $17.93M | $18.28M | $12.91M | $11.25M | $8.88M | $13.92M | $11.33M | $7.35M | $14.22M |
| Revenue Growth? | -28.6% | -1.9% | +41.6% | +14.8% | +26.6% | -36.2% | +22.8% | +54.1% | -48.3% | 0.0% |
| Cost of Revenue? | $5.95M | $8.41M | $9.20M | $6.70M | $4.50M | $3.81M | $7.15M | $7.02M | $5.28M | $11.27M |
| Gross Profit? | $6.84M | $9.51M | $9.08M | $6.21M | $6.75M | $5.07M | $6.76M | $4.31M | $2.07M | $2.95M |
| Gross Margin? | +53.5% | +53.1% | +49.7% | +48.1% | +60.0% | +57.1% | +48.6% | +38.0% | +28.1% | +20.7% |
| Operating Expenses? | $20.17M | $19.97M | $24.19M | $21.77M | $20.58M | $17.93M | $23.40M | $31.37M | $33.35M | $30.73M |
| Operating Income? | -$13.33M | -$10.46M | -$15.11M | -$15.56M | -$13.83M | -$12.86M | -$16.64M | -$27.03M | -$31.61M | -$27.59M |
| EBITDA? | -$9.81M | -$9.45M | -$13.20M | -$14.04M | -$9.09M | -$15.07M | -$11.06M | -$24.89M | -$26.74M | -$21.60M |
| Income Before Tax | -$11.70M | -$11.33M | -$15.20M | -$15.08M | -$9.76M | -$15.82M | -$12.13M | -$26.99M | -$29.12M | -$23.47M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$11.70M | -$11.33M | -$15.20M | -$15.08M | -$9.76M | -$15.82M | -$12.13M | -$26.99M | -$29.12M | -$23.47M |
| EPS? | $-4.91 | $-8.43 | $-16.44 | $-17.45 | $-12.01 | $-33.13 | $-37.96 | $-99.19 | $-184.01 | $-419.75 |
| Diluted EPS? | $-4.91 | $-8.43 | $-16.44 | $-17.45 | $-13.20 | $-33.13 | $-37.96 | $-99.19 | $-184.01 | $-419.75 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality